Omers Administration Corp Akebia Therapeutics, Inc. Transaction History

Omers Administration Corp

  • $10.4 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$1.27 - $2.24 $97,790 - $172,480
77,000 New
77,000 $140,000
Q4 2018

Feb 14, 2019
SELL
$5.39 - $9.15 $1.4 Million - $2.38 Million
-259,830 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$7.44 - $10.65 $1.52 Million - $2.17 Million
204,030 Added 365.65%
259,830 $2.29 Million
Q2 2018

Aug 09, 2018
BUY
$9.15 - $11.34 $510,570 - $632,772
55,800 New
55,800 $557,000

Others Institutions Holding AKBA

# of Institutions
121
Shares Held
54.8M
Call Options Held
291K
Put Options Held
179K
View Full List

About Akebia Therapeutics, Inc.

AKBA Quotes by TradingView
  • Ticker AKBA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 183,848,992
  • Market Cap $329M
  • Description
  • Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...
More about AKBA
Track This Portfolio

Track Omers Administration Corp Portfolio

Follow Omers Administration Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Omers Administration Corp, based on Form 13F filings with the SEC.

News

Stay updated on Omers Administration Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email